| Title | Author(s) | Issue date | ???itemlist.??? |
| Biochemical characterization of pediatric brain tumors by using in vivo and ex vivo magnetic resonance spectroscopy | Tzika, A. A.; Cheng, L. L.; Goumnerova, L.; Madsen, J. R.; Zurakowski, D.; Astrakas, L. G.; Zarifi, M. K.; Scott, R. M.; Anthony, D. C.; Gonzalez, R. G.; Black, P. M. | 24-Nov-2015 | - |
| Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies | Tzika, A. A.; Astrakas, L.; Cao, H. H.; Mintzopoulos, D.; Andronesi, O. C.; Mindrinos, M.; Zhang, J. W.; Rahme, L. G.; Blekas, K.; Likas, A. C.; Galatsanos, N. P.; Carroll, R. S.; Black, P. M. | 24-Nov-2015 | - |
| Combining magnetic resonance spectroscopy and molecular genomics offers better accuracy in brain tumor typing and prediction of survival than either methodology alone | Astrakas, L.; Blekas, K.; Constantinou, C.; Andronesi, O. C.; Mindrinos, M. N.; Likas, A. C.; Rahme, L. G.; Black, P. M.; Marcus, K. J.; Tzika, A. A. | 24-Nov-2015 | - |
| Molecular classification of brain tumor biopsies using solid-state magic angle spinning proton magnetic resonance spectroscopy and robust classifiers | Andronesi, O. C.; Blekas, K.; Mintzopoulos, D.; Astrakas, L.; Black, P. M.; Tzika, A. A. | 24-Nov-2015 | - |
| Multiparametric MR assessment of pediatric brain tumors | Tzika, A. A.; Astrakas, L. G.; Zarifi, M. K.; Petridou, N.; Young-Poussaint, T.; Goumnerova, L.; Zurakowski, D.; Anthony, D. C.; Black, P. M. | 24-Nov-2015 | - |
| Neuroimaging in pediatric brain tumors: Gd-DTPA-enhanced, hemodynamic, and diffusion MR imaging compared with MR spectroscopic imaging | Tzika, A. A.; Zarifi, M. K.; Goumnerova, L.; Astrakas, L. G.; Zurakowski, D.; Young-Poussaint, T.; Anthony, D. C.; Scott, R. M.; Black, P. M. | 24-Nov-2015 | - |
| Noninvasive magnetic resonance spectroscopic imaging biomarkers to predict the clinical grade of pediatric brain tumors | Astrakas, L. G.; Zurakowski, D.; Tzika, A. A.; Zarifi, M. K.; Anthony, D. C.; De Girolami, U.; Tarbell, N. J.; Black, P. M. | 24-Nov-2015 | - |
| Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas | Fine, H. A.; Figg, W. D.; Jaeckle, K.; Wen, P. Y.; Kyritsis, A. P.; Loeffler, J. S.; Levin, V. A.; Black, P. M.; Kaplan, R.; Pluda, J. M.; Yung, W. K. | 24-Nov-2015 | - |
| Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers | Marcus, K. J.; Astrakas, L. G.; Zurakowski, D.; Zarifi, M. K.; Mintzopoulos, D.; Poussaint, T. Y.; Anthony, D. C.; De Girolami, U.; Black, P. M.; Tarbell, N. J.; Tzika, A. A. | 24-Nov-2015 | - |
| Proton magnetic spectroscopic imaging of the child's brain: the response of tumors to treatment | Tzika, A. A.; Zurakowski, D.; Poussaint, T. Y.; Goumnerova, L.; Astrakas, L. G.; Barnes, P. D.; Anthony, D. C.; Billett, A. L.; Tarbell, N. J.; Scott, R. M.; Black, P. M. | 24-Nov-2015 | - |
| Spectroscopic and perfusion magnetic resonance imaging predictors of progression in pediatric brain tumors | Tzika, A. A.; Astrakas, L. G.; Zarifi, M. K.; Zurakowski, D.; Poussaint, T. Y.; Goumnerova, L.; Tarbell, N. J.; Black, P. M. | 24-Nov-2015 | - |
